参考文献/References:
[1] 支伟伟,苏 哲,殷 强.基质金属蛋白酶2/9在大鼠颈动脉迂曲形成中的发生机制研究[J].陕西医学杂志,2018,47(10):1227-1229.
[2] 郭俊林,张 立.基质金属蛋白酶-2与冠状动脉粥样硬化性疾病的研究进展[J].医学信息,2018,31(4):27-30.
[3] 宋宜生,吴小三,王聪霞,等.血管生成素、基质金属蛋白酶-2在冠心病中的表达及相关性研究[J].陕西医学杂志,2014,43(3):275-278.
[4] Hu B,Jarzynka MJ,Guo P,et al.Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway[J].Cancer Res,2006,66(2):775-783.
[5] 南格利.冠心病颈动脉超声参数与斑块稳定性及炎症反应水平相关性分析[J].陕西医学杂志,2020,49(4):453-457.
[6] 胡宇才,董 倩,秦元梅,等.冠心丹参滴丸治疗冠心病心绞痛疗效与安全性系统评价[J].陕西中医,2021,42(1):124-130.
[7] 张灵利,何艳杰,李 红.幽门螺旋杆菌相关胃病不同中医证候患者胃黏膜MMP-2、TIMP-1的表达及临床意义[J].陕西中医,2020,41(3):353-356.
[8] Chen L,Yang Q,Ding R,et al.Carotid thickness and atherosclerotic plaque stability,serum inflammation,serum MMP-2 and MMP-9 were associated with acute cerebral infarction[J].Exp Ther Med,2018,16(6):5253-5257.
[9] Soliman AR,Sadek KM,Thabet KK,et al.The role of matrix metalloproteinases 2 in atherosclerosis of patients with chronic kidney disease in type 2 diabetes[J].Saudi J Kidney Dis Transpl,2019,30(2):387-393.
[10] Hardy E,Hardy-Sosa A,Fernandez-Patron C.MMP-2:Is too low as bad as too high in the cardiovascular system[J].Am J Physiol Heart Circ Physiol,2018,315(5):1332-1340.
[11] 李 瑞,孟照辉.基质金属蛋白酶在冠心病研究中的进展[J].临床医学,2017,37(8):123-126,封3.
[12] Xu Y,Zhang Y,Wang Z,et al.The role of serum angiopoietin-2 levels in progression and prognosis of lung cancer:A meta-analysis[J].Medicine(Baltimore),2017,96(37):e8063.
[13] Yu X,Ye F.Role of angiopoietins in development of cancer and neoplasia associated with viral infection[J].Cells,2020,9(2):457.
[14] Hu B,Guo P,Fang Q,et al.Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2[J].Proc Natl Acad Sci USA,2003,100(15):8904-8909.
[15] Nicolini G,Forini F,Kusmic C,et al.Angiopoietin 2 signal complexity in cardiovascular disease and cancer[J].Life Sci,2019,239:117080.
[16] Wu Q,Xu WD,Huang AF.Role of angiopoietin-2 in inflammatory autoimmune diseases:A comprehensive review[J].Int Immunopharmacol,2020,80:106223.
[17] Andrawes NG,Ismail EA,Roshdy MM,et al.Angiopoietin-2 as a marker of retinopathy in children and adolescents with sickle cell disease:relation to subclinical atherosclerosis[J].J Pediatr Hematol Oncol,2019,41(5):361-370.
[18] Theelen TL,Lappalainen JP,Sluimer JC,et al.Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice[J].Atherosclerosis,2015,241(2):297-304.
[19] Lee KW,Lip GY,Blann AD.Plasma angiopoietin-1,angiopoietin-2,angiopoietin receptor tie-2,and vascular endothelial growth factor levels in acute coronary syndromes[J].Circulation,2004,110(16):2355-2360.
[20] Zeng ZY,Gui C,Li L,et al.Effects of percutaneous coronary intervention on serum angiopoietin-2 in patients with coronary heart disease[J].Chin Med J(Engl),2016,129(6):631-635.
[21] Wu H,Shou X,Liang L,et al.Correlation between plasma angiopoietin-1,angiopoietin-2 and matrix metalloproteinase-2 in coronary heart disease[J].Arch Med Sci,2016,12(6):1214-1219.